Surgery, Gastroenterology and Oncology
Vol. 26, No. 3, Sept 2021
Intraductal Papillary Mucinous Neoplasm Recurrence 10 Years after Duodenopancreatectomy. Laparoscopic Resection (with video)
Javier Chinelli, Graciela Hernandez, Carlos Perez, Elisa Laca, Gustavo Rodríguez
Video Case Report, Sept 2021
Article DOI: 10.21614/sgo-26-3-361


Pancreatic adenocarcinoma has a poor prognosis, even after R0 resections. Metachronous disease usually arises as distant or regional metastasis, but local recurrence is infrequent. 66 year-old male patient with a subclinical pancreatic remnant lesion suspected to be malignant 10 years after duodenopancreatectomy for invasive mucinous cystoadenocarcinoma. After distant metastatic disease was ruled-out, laparoscopic distal pancreatectomy was performed. Pathology revealed a non-invasive intraductal papillary mucinous neoplasm (IPMN).
The decision to resect metachronous disease after pancreatic cancer surgery remains under debate, based on the type of recurrence. Pancreatic remnant lesions can be true recurrences or new primary tumors.
In this case, pathology suggests a slow growth recurrence or a second primary tumor. Patients with local recurrence alone and prolonged disease-free survival like this might benefit from surgical resection. This case highlights the importance of long-term follow-up of malignant pancreatic cystic tumors, as surgical treatment of local recurrences could be potentially curative.
In the present case this was achieved successfully through a technically challenging minimally invasive approach.

Full Text Sources: Download pdf
Abstract:   Abstract EN
Views: 1844


Watch Video Articles


For Authors



Journal Subscriptions

Current Issue

Jun 2025

Supplements

Instructions for authors
Online submission
Contact
ISSN: 2559 - 723X (print)

e-ISSN: 2601 - 1700 (online)

ISSN-L: 2559 - 723X

Journal Abbreviation: Surg. Gastroenterol. Oncol.

Surgery, Gastroenterology and Oncology (SGO) is indexed in:
  • SCOPUS
  • EBSCO
  • DOI/Crossref
  • Google Scholar
  • SCImago
  • Harvard Library
  • Open Academic Journals Index (OAJI)

Open Access Statement

Surgery, Gastroenterology and Oncology (SGO) is an open-access, peer-reviewed online journal published by Celsius Publishing House. The journal allows readers to read, download, copy, distribute, print, search, or link to the full text of its articles.

Journal Metrics

Time to first editorial decision: 25 days
Rejection rate: 61%
CiteScore: 0.2



Meetings and Courses in 2025
Meetings and Courses in 2024
Meetings and Courses in 2023
Meetings and Courses in 2022
Meetings and Courses in 2021
Meetings and Courses in 2020
Meetings and Courses in 2019
Verona expert meeting 2019

Creative Commons License
Surgery, Gastroenterology and Oncology applies the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits readers to copy and redistribute the material in any medium or format, remix, adapt, build upon the published works non-commercially, and license the derivative works on different terms, provided the original material is properly cited and the use is non-commercial. Please see: https://creativecommons.org/licenses/by-nc/4.0/
Publisher’s Note:
The opinions, statements, and data contained in article are solely those of the authors and not of Surgery, Gastroenterology and Oncology journal or the editors. Publisher and the editors disclaim responsibility for any damage resulting from any ideas, instructions, methods, or products referred to in the content.